Cargando…
What predicts survival in glioblastoma? A population-based study of changes in clinical management and outcome
BACKGROUND: Glioblastoma is the most common and most aggressive primary brain tumor in adults. Despite multimodal treatment, the median survival time is 15–16 months and 5-year survival rate 5%–10%. The primary goal of this study was to identify prognostic factors for survival in an unselected popul...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498299/ https://www.ncbi.nlm.nih.gov/pubmed/37711136 http://dx.doi.org/10.3389/fsurg.2023.1249366 |